| The identification of novel germline modifiers of aggressive prostate cancer development |
Nigel Crawford |
NHGRI, DIR, GMBB |
PLCO |
Mar 25, 2014 |
PLCO-72 |
| Building a large imputation panel for a publicly available server to impute GWAS data |
Ulrike Peters |
Fred Hutchinson Cancer Center |
PLCO |
Mar 20, 2014 |
PLCO-70 |
| Thyroid Cancer and NSAIDs |
Jigarkumar Patel |
NCI, DCP, GOCRG |
PLCO |
Mar 12, 2014 |
PLCO-69 |
| Expanded evaluation of markers of human papillomavirus (HPV) infection and cancer at multiple anatomic sites - using PLCO data to bolster the cohort consortium effort |
Aimee Kreimer |
NCI, DCEG, IIB |
PLCO |
Mar 7, 2014 |
2014-0037 |
| Pre-diagnostic serum metabolomic profiling and risk of prostate cancer |
Demetrius Albanes |
NCI |
PLCO |
Mar 7, 2014 |
2014-0030 |
| Serum vitamin D binding protein and risk of renal cell carcinoma |
Alison Mondul |
University of Michigan |
PLCO |
Mar 7, 2014 |
2014-0027 |
| Vitamin D, Vitamin D Binding Protein and Prostate Cancer Risk in African American Men |
Demetrius Albanes |
NCI, DCEG |
PLCO |
Mar 7, 2014 |
2014-0020 |
| Identify high-risk susceptibility genes for melanoma using population-based samples to follow-up on rare variants in potential melanoma susceptibility genes identified from melanoma-prone families |
Rose Yang |
NCI, DCEG, GEB |
PLCO |
Mar 7, 2014 |
2014-0017 |
| Metabolic profiling of serum in a prospective renal cell carcinoma study |
Loren Lipworth |
Vanderbilt University |
PLCO |
Mar 7, 2014 |
2014-0007 |
| Utilizing sequence and imputed genotype data to identify novel genetic susceptibility variants for colorectal cancer |
Ulrike Peters |
Fred Hutchinson Cancer Center |
PLCO |
Mar 6, 2014 |
PLCO-68 |
| Using decision support technologies to enhance individual decision-making to forgo or undergo screening for prostate cancer |
Andrew Stephenson |
Cleveland Clinic |
PLCO |
Feb 27, 2014 |
PLCO-66 |
| Influence of analgesic medication use on circulating estrogens and estrogen metabolites (EM) in samples of postmenopausal women from the PLCO cohort |
Barbara Fuhrman |
University of Arkansas for Medical Sciences |
PLCO |
Feb 14, 2014 |
PLCO-61 |
| Pro-Inflammatory Dietary Factors in Prostate Cancer Susceptibility and Survival |
Zuo-Feng Zhang |
University of California - Los Angeles |
PLCO |
Feb 10, 2014 |
PLCO-65 |
| Weight change across the adult life course in relation to total, aggressive and lethal prostate cancer |
Michael Cook |
NCI, DCEG, HREB |
PLCO |
Feb 3, 2014 |
PLCO-64 |
| Pre-diagnostic aspirin use, lymph node involvement and mortality in women with stage I-III breast cancer. |
Marie Bradley |
NCI, DCCPS, CTEB |
PLCO |
Feb 3, 2014 |
PLCO-62 |
| prediction of lung cancer at early stage |
prashant naresh |
RVCE |
PLCO |
Feb 3, 2014 |
PLCO-63 |
| Clinical Decision Support for Calculating Patient Cancer Risk |
James Morrison |
University of Maryland |
PLCO |
Jan 29, 2014 |
PLCO-60 |
| PSA-development as function of time for young men |
Ottokar Schuetz |
SHG-Uro-SBH |
PLCO |
Jan 22, 2014 |
PLCO-59 |
| NSAIDS and Esophageal and Stomach Cancer |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jan 16, 2014 |
PLCO-58 |
| Comparison of the PLCO data with the ovarian cancer screening data in Japan |
Noriomi Matsumura |
Kyoto University |
PLCO |
Jan 15, 2014 |
PLCO-56 |
